Who owns CITIUS ONCOLOGY INC?
- Ticker: CTOR
- CUSIP Number: 17331y109
Tip: Access positions for across all investors
Analyze quarterly positions in Citius Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Citius Oncology stock
Who bought or sold CITIUS ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 7.7M | $16M | 100% | Sep 2025 |
|
| Vanguard Group | 180k | $366k | 100% | Sep 2025 |
|
| Geode Capital Management | 167k | $339k | 192% | Sep 2025 |
|
| XTX Topco | 127k | $258k | 100% | Sep 2025 |
|
| Renaissance Technologies | 56k | $114k | 100% | Sep 2025 |
|
| State Street Corporation | 43k | $87k | 100% | Sep 2025 |
|
| IFP Advisors | 33k | $67k | 50% | Sep 2025 |
|
| Northern Trust | 22k | $44k | 100% | Sep 2025 |
|
| Citadel Advisors | 18k | $36k | 100% | Sep 2025 |
|
| Tower Research Capital | 12k | $24k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 12k | $25k | 120% | Sep 2025 |
|
| Arkadios Wealth Advisors | 12k | $24k | 0% | Sep 2025 |
|
| UBS Group | 55.00 | $112.002000 | -100% | Sep 2025 |
|
| Farther Finance Advisors | 3.00 | $6.000000 | 100% | Sep 2025 |
|
Who sold out of Citius Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Jun 2025 | 107k | $465k |